Baird Capital leads $28M funding round for Atlanta cancer treatment analytics startup
May 27, 2020 at 18:03 PM EDT
Michael Liang, partner at Chicago-based Baird Capital, has joined Oncology Analytics’ board of directors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|